SEC-sourced researchBeta

NUTX

Nutex Health Inc.

US markets

Data passport

CIK: 0001479681
Exchange: Nasdaq
Business activity: — · SIC 7389
Financial inputs: 6/6
Filing date: Sep 22, 2026
SEC registry record: Operating company

Last updated: Oct 6, 2026, 12:03 PM UTCSEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Chart metric

NUTX · Exact amounts and source periods · USD
Period end	Revenue	Filing date
December 2023	247,646,000.0000	Mar 5, 2026
December 2024	479,949,000.0000	Mar 5, 2026
December 2025	875,257,000.0000	Mar 5, 2026

Annual periods · USD

Period end	Revenue	Net income	Operating cash flow	Total assets	Total liabilities	Filing date
December 2025	875,257,000.0000	70,789,000.0000	248,125,000.0000	918,525,000.0000	495,088,000.0000	Mar 5, 2026
December 2024	479,949,000.0000	52,097,000.0000	23,153,000.0000	655,320,000.0000	466,787,000.0000	Mar 5, 2026
December 2023	247,646,000.0000	-45,787,000.0000	1,257,000.0000	—	—	Mar 5, 2026

Financial inputs behind the calculation

Financial inputs	USD	Period end	Filing date	Form
RevenueRevenues	$875.26M	December 2025	Mar 5, 2026	10-K
Previous period revenueRevenues	$479.95M	December 2024	Mar 5, 2026	10-K
Net incomeNetIncomeLoss	$70.79M	December 2025	Mar 5, 2026	10-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities	$248.13M	December 2025	Mar 5, 2026	10-K
Total assetsAssets	$918.53M	December 2025	Mar 5, 2026	10-K
Total liabilitiesLiabilities	$495.09M	December 2025	Mar 5, 2026	10-K

New filings

Explore methodology ↗